Business in the Burbs

Par enters licensing agreement

January

Alfacell Corp., a pharmaceutical company based in Somerset, N.J., announced a license agreement with Strativa Pharmaceuticals, a subsidiary of Par Pharmaceutical Cos. Inc. The agreement covers the commercialization of the cancer treatment Onconase in the United States. Par, which is based in Woodcliff Lake, N.J., employs about 400 people in Chestnut Ridge.

This entry was posted on Tuesday, January 15th, 2008 at 11:43 am by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: | Print Print | Email Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.

Business in the Burbs

Movers, shakers and newsmakers

Par enters licensing agreement

Leave a Reply

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Par enters licensing agreement

Leave a Reply